Is Gritstone bio, Inc. (GRTS) a Buy, Sell, or Hold?
NASDAQ : GRTS
Gritstone bio, Inc. — Analyst Ratings
$0.0322 USD
-$0.01 (-31.78%)
- Volume
- 55.25M
- Average Volume
- 17.68M
- Market Capitalization
- $3.8M
- P/E Ratio
- -0.03
- Dividend Yield
- 0.00%
- Price Target
- $5.00
- Year High
- $3.17
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.20
Analyst Consensus Summary
Consensus Rating
N/A
13 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-99.4%
vs Current Price
Price Target
$5.00
Average TargetPrice Target Range
Lowest Target
$3.00
-98.9% DOWNSIDE
Average Target
$5.00
Median Estimate
Highest Target
$6.00
-99.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 13
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 4 | 2 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| BTIG | Kaveri Pohlman | $3 | $1.2 | 2024-04-02 09:58 AM | 150.0% |
| JMP Securities | Roy Buchanan | $5 | $2.35 | 2024-04-01 10:23 PM | 112.8% |
| Piper Sandler | Edward Tenthoff | $6 | $2.71 | 2022-10-30 03:22 PM | 121.4% |